Apoptose
Os inibidores da apoptose são compostos que previnem ou retardam o processo de morte celular programada, conhecido como apoptose. Esses inibidores são vitais no estudo dos mecanismos de sobrevivência celular e são usados para investigar doenças onde a apoptose é desregulada, como câncer, distúrbios neurodegenerativos e doenças autoimunes. Ao modular a apoptose, esses inibidores podem ajudar no desenvolvimento de terapias destinadas a controlar a morte celular. Na CymitQuimica, oferecemos uma ampla seleção de inibidores da apoptose de alta qualidade para apoiar sua pesquisa em biologia celular, oncologia e áreas relacionadas.
Subcategorias de "Apoptose"
- ASK(6 produtos)
- BCL(11 produtos)
- Caspase(125 produtos)
- FOXO1(3 produtos)
- IAP(66 produtos)
- Mdm2(12 produtos)
- PD-1/PD-L1(125 produtos)
- PDK(9 produtos)
- PERK(25 produtos)
- Serina/treonina quinase(15 produtos)
- Survivina(13 produtos)
- TNF(92 produtos)
- c-RET(51 produtos)
- p53(62 produtos)
Exibir 6 mais subcategorias
Foram encontrados 5599 produtos de "Apoptose"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
NSC-639829
CAS:<p>NSC-639829 is an anti-tumor compound that requires a solubilizing agent for dissolution.</p>Fórmula:C21H20BrN5O3Pureza:99.53% - 99.77%Cor e Forma:SolidPeso molecular:470.32CCT373566
CAS:<p>CCT373566: potent BCL6 degrader, oral, IC50 2.2 nM; hinders cell growth in vitro & shrinks tumors in vivo.</p>Fórmula:C26H29ClF2N6O3Cor e Forma:SolidPeso molecular:547Apoptotic agent-3
CAS:<p>"Apoptotic agent-3 targets Bcl-2/Bax, activates caspase-3, and has anti-proliferative properties for cancer research."</p>Fórmula:C31H21N5OSCor e Forma:SolidPeso molecular:511.6QTX125
CAS:<p>QTX125: potent, selective HDAC6 inhibitor with strong antitumor effects.</p>Fórmula:C23H19N3O5Cor e Forma:SolidPeso molecular:417.41Topoisomerase II inhibitor 7
CAS:<p>Topoisomerase II inhibitor 7 halts cell division and induces apoptosis, targeting topoisomerase II alpha with a 3.19 μM IC50.</p>Fórmula:C32H28BrN5O5SCor e Forma:SolidPeso molecular:674.56ATX inhibitor 13
CAS:<p>ATX inhibitor 13: orally active, IC50 3.4 nM, halts RAW264.7 cells at G2, curbs growth/migration, prompts apoptosis, suppresses tumors.</p>Fórmula:C31H35Cl2N5O3Cor e Forma:SolidPeso molecular:596.55A-385358
CAS:<p>A-385358 is a selective Bcl-xL inhibitor with Kis of 0.80 nM for Bcl-xL and 67 nM for Bcl-2, respectively.</p>Fórmula:C32H41N5O5S2Pureza:99.97%Cor e Forma:SolidPeso molecular:639.83PIK-C98
CAS:<p>PIK-C98 is an inhibitor of PI3K that acts by displaying potent preclinical activity against multiple myeloma.</p>Fórmula:C16H10Cl2N2OSPureza:98%Cor e Forma:SolidPeso molecular:349.23p53 Activator 5
CAS:<p>Potent p53 Activator 5, SC150 <0.05 mM, restores mutant p53 DNA binding, exhibits anti-tumor properties.</p>Fórmula:C29H32F6N4OCor e Forma:SolidPeso molecular:566.58Metoprolol fumarate
CAS:<p>Metoprolol fumarate (CGP 2175C): selective β1-blocker with anti-inflammatory, antitumor, anti-angiogenic effects.</p>Fórmula:C34H54N2O10Cor e Forma:SolidPeso molecular:650.8Shield-2
CAS:<p>Shield-2 is a potent FKBP-derived destabilizing domain stabilizing ligand.</p>Fórmula:C35H51N3O7Pureza:98%Cor e Forma:SolidPeso molecular:625.8MMP2-IN-1
CAS:<p>MMP2-IN-1, an MMP2 inhibitor (IC50 = 6.8μM), halts growth and induces apoptosis in some cancers.</p>Fórmula:C15H13NO5SCor e Forma:SolidPeso molecular:319.33Quinidine polygalacturonate
CAS:<p>Quinidine polygalacturonate: oral cytochrome P450db inhibitor, K+ channel blocker (IC50 19.9 μM), induces apoptosis, anti-arrhythmic, aids malaria research.</p>Fórmula:C26H34N2O9Cor e Forma:SolidPeso molecular:518.22643ZT55
CAS:<p>ZT55: Oral JAK2 inhibitor, IC50: 0.031 μM, hinders JAK2 V617F HEL cell growth, induces apoptosis, arrests cell cycle, effective in mice HEL tumor studies.</p>Fórmula:C17H16N2O3Cor e Forma:SolidPeso molecular:296.32BLM-IN-2
<p>BLM-IN-2: BLM inhibitor, IC50=0.8 μM; hinders CRC cell growth, invasion, cycle arrest, and death.</p>Fórmula:C33H38BrFN4OCor e Forma:SolidPeso molecular:605.58SIRT6 activator 12q
CAS:<p>SIRT6 activator 12q: potent, selective, oral; IC50 - SIRT1: 171.20μM, SIRT6: 0.58μM; halts cell growth/migration, induces apoptosis, G2 arrest, anticancer.</p>Fórmula:C31H22N2O2Cor e Forma:SolidPeso molecular:454.52CEP-1612
CAS:<p>CEP-1612 inhibits protein breakdown, regulates cell cycles, apoptosis, boosts p21/p27 expression, and curbs lung cancer growth.</p>Fórmula:C35H53N7O7Cor e Forma:SolidPeso molecular:683.84SKLB0565
CAS:<p>SKLB0565 inhibits tubulin and colorectal cancer growth (IC50: 0.012-0.081 μM), causes G2/M arrest, triggers apoptosis, and prevents HUVEC migration.</p>Fórmula:C20H25ClN6OCor e Forma:SolidPeso molecular:400.91S-Gem
CAS:<p>S-Gem, a thioredoxin reductase (TrxR)-dependent prodrug of Gemcitabine, is selectively activated by TrxR.</p>Fórmula:C13H15F2N3O6S2Pureza:98%Cor e Forma:SolidPeso molecular:411.4Selicrelumab
CAS:<p>Selicrelumab (RG-7876) is an antibody targeting CD40 with potential anti-tumor activity for the study of pancreatic cancer.</p>Pureza:98.7% (SDS-PAGE); 95.2% (SEC-HPLC) - 98.7% (SDS-PAGE); 95.2% (SEC-HPLC)Cor e Forma:LiquidAntiproliferative agent-7
CAS:<p>Antiproliferative agent-7 (compound 8f) is a potent anti-proliferative agent. Antiproliferative agent-7 can promote ROS production and induce apoptosis.</p>Fórmula:C28H32N4OCor e Forma:SolidPeso molecular:440.58AG-024322
CAS:<p>AG-024322 is a pan-CDK inhibitor with antitumor activity, induces apoptosis, and can be used in the study of metabolic diseases.</p>Fórmula:C23H20F2N6Pureza:98.53%Cor e Forma:SolidPeso molecular:418.44SKLB70326
CAS:<p>SKLB70326 is a cell-cycle progression inhibitor that acts by inducing G0/G1 phase arrest and apoptosis in human hepatic carcinoma cells.</p>Fórmula:C15H13N3O2SPureza:98%Cor e Forma:SolidPeso molecular:299.35PDE5-IN-3
CAS:<p>PDE5-IN-3: Inhibits PDE5 (1.57 nM), EGFR (5.827 μM), Wnt pathway (1286.96 ng/mL), induces apoptosis, and has antitumor effects.</p>Fórmula:C21H14BrN5O2Cor e Forma:SolidPeso molecular:448.27Dipin
CAS:<p>Dipin is an Antineoplastic.</p>Fórmula:C12H24N6O2P2Pureza:98%Cor e Forma:SolidPeso molecular:346.31PHA-690509
CAS:<p>PHA-690509 is a cyclin-dependent kinase 2 inhibitor. It potentially for the treatment of cancer.</p>Fórmula:C17H21N3O2SPureza:98%Cor e Forma:SolidPeso molecular:331.43Antitumor agent-83
<p>Antitumor agent-83 activates BAX protein, impedes tumor growth, triggers apoptosis, and is stable in vitro.</p>Fórmula:C29H30N6O2Cor e Forma:SolidPeso molecular:494.59Atopaxar
CAS:<p>Atopaxar (E5555), a reversible PAR-1 thrombin receptor antagonist, interferes with platelet signaling.</p>Fórmula:C29H38FN3O5Pureza:97.07% - 98.07%Cor e Forma:SolidPeso molecular:527.63CAY10506
CAS:<p>CAY10506, a hybrid lipoic acid-TZD, activates PPARγ to control glucose and lipid levels with an EC50 of 10 μM.</p>Fórmula:C20H26N2O4S3Cor e Forma:SolidPeso molecular:454.63PhiKan 083 hydrochloride
CAS:<p>PhiKan 083 HCl: carbazole, binds Y220C (Kd 167 μM), affinity in Ln229 (Kd 150 μM).</p>Fórmula:C16H19ClN2Pureza:98%Cor e Forma:SolidPeso molecular:274.79Mutant p53 modulator-1
CAS:<p>Mutant p53 modulator-1 inhibits cancer with p53 mutations; see patent WO2021231474A1, compound 231B.</p>Fórmula:C27H32F4N8O2Cor e Forma:SolidPeso molecular:576.59FKGK 18
CAS:<p>FKGK 18: GVIA iPLA2 inhibitor, 99.9% at 0.091 fraction, selective, IC50 ~50 nM–3 μM, reduces blood glucose and diabetes in NOD mice.</p>Fórmula:C16H15F3OCor e Forma:SolidPeso molecular:280.28QM31
CAS:<p>QM31 is a selective Apaf-1 inhibitor(inbitita formation of the apoptosome with IC50 of 7.9μM).</p>Fórmula:C39H38Cl4N4O4Pureza:98%Cor e Forma:SolidPeso molecular:768.56RIP1 kinase inhibitor 6
CAS:<p>RIP1 Kinase Inhibitor 6 is a potent and selective inhibitor of RIP1 kinase, demonstrating inhibitory activity with an IC50 of less than 100 nM in a human R1P1</p>Fórmula:C19H18F2N2O3Pureza:98%Cor e Forma:SolidPeso molecular:360.35EGFR-IN-59
CAS:<p>EGFR-IN-59: EGFR inhibitor, IC50 = 190 nM, induces apoptosis, cytotoxic to A549 cells (IC50 = 8.62 μM) and WI38 cells (IC50 = 52.6 μM). Use: Various cancers.</p>Fórmula:C27H23N5O4SCor e Forma:SolidPeso molecular:513.57RET-IN-8
CAS:<p>RET-IN-8 is an inhibitor of rearrangement kinase (RET) during transfection and can be used in cancer research.</p>Fórmula:C27H30N6O3Cor e Forma:SolidPeso molecular:486.57Sanazole
CAS:<p>Sanazole is a 3-nitrotriazole cpd. It can affect the human cervical cancer cell line.</p>Fórmula:C7H11N5O4Cor e Forma:SolidPeso molecular:229.19AZD-5991 Racemate
CAS:<p>AZD-5991 Racemate is the racemate of AZD-5991. (Rac)-AZD-5991 is a novel Mcl-1 inhibitor induces upregulation of BCL2,BCL-XL, CMYC and MCL1 in AML cell lines.</p>Fórmula:C35H34ClN5O3S2Cor e Forma:SolidPeso molecular:672.26Mcl1-IN-11
CAS:<p>Mcl1-IN-11 (Compound G) is a selective Mcl-1 inhibitor, less potent at Bcl-2, with Kis of 0.06 and 4.2 μM, respectively.</p>Fórmula:C38H41N3O5S2Pureza:98%Cor e Forma:SolidPeso molecular:683.88DX2-201
CAS:<p>DX2-201 is a potent and selective inhibitor of oxidative phosphorylation (OXPHOS) complex I (IC50: 312 nM) and exhibits anticancer activity.</p>Fórmula:C18H28N2O6S2Cor e Forma:SolidPeso molecular:432.55Declopramide
CAS:<p>Declopramide (OXI-104) is a chemosensitizer with antitumor activity that can be used to study colorectal cancer and inflammatory bowel disease.</p>Fórmula:C13H20ClN3OPureza:98.53%Cor e Forma:SolidPeso molecular:269.77SB-218078
CAS:<p>SB-218078 is less potently inhibits Cdc2 (IC50: 250 nM) and PKC (IC50: 1000 nM).</p>Fórmula:C24H15N3O3Pureza:98%Cor e Forma:SolidPeso molecular:393.39EGFR-IN-46
CAS:<p>EGFR-IN-46: Potent EGFR/FAK inhibitor (IC50: 20.17 & 14.25 nM), curbs cancer cell growth, triggers apoptosis.</p>Fórmula:C27H32F3N3O3Cor e Forma:SolidPeso molecular:503.56Tubulin/HDAC-IN-1
CAS:<p>Tubulin/HDAC-IN-1 is a dual inhibitor for tubulin & HDAC8, blocking polymerization & targeting HDAC8 (IC50: 150 nM), and induces cancer cell apoptosis.</p>Fórmula:C21H18N4O3Cor e Forma:SolidPeso molecular:374.39PD-1/PD-L1-IN-14
CAS:<p>PD-1/PD-L1-IN-14 (compound 17) is an inhibitor of PD-1/PD-L1 interaction (IC50=27.8 nM).</p>Fórmula:C24H24N4O2Cor e Forma:SolidPeso molecular:400.47T-3256336
CAS:<p>T-3256336 is an oral IAP blocker targeting cIAP-1, cIAP-2, and XIAP.</p>Fórmula:C31H45F2N5O5Pureza:98%Cor e Forma:SolidPeso molecular:605.72BTK-IN-9
CAS:<p>BTK-IN-9 reversibly inhibits BTK, disrupts mitochondria, boosts ROS, and triggers apoptosis in Z138 cells, impeding condyloma cell growth.</p>Fórmula:C25H19N7O4Cor e Forma:SolidPeso molecular:481.46Pentabromophenol
CAS:<p>Pentabromophenol (NSC-5717) suppressed TGF-β response by accelerating the turnover rate of TGF-β receptors.</p>Fórmula:C6HBr5OPureza:99.83%Cor e Forma:Monoclinic Prisms From Acetic Acid; Needles From Alcohol Physical Description Light Brown Powder Insoluble In Water (Ntp 1992)Peso molecular:488.59RIPK1-IN-3
CAS:<p>RIPK1-IN-3 is a RIPK1 inhibitor, with anti-inflammatory proprieties.</p>Fórmula:C22H19F3N6O3Pureza:98%Cor e Forma:SolidPeso molecular:472.42Anti-inflammatory agent 11
CAS:<p>Potent anti-inflammatory compound 16 combats tuberculosis, inhibiting Mtb H37Rv and M299 (MICs: 1.3, 6.9 μM) and reduces NO, TNF-α, IL-1β production.</p>Fórmula:C14H14N4OSCor e Forma:SolidPeso molecular:286.35DCP-LA
CAS:<p>DCP-LA (FR236924), linoleic acid derivatives, selective and direct activation of PKCε.</p>Fórmula:C20H36O2Pureza:98%Cor e Forma:SolidPeso molecular:308.5MCL-1/BCL-2-IN-4
CAS:<p>MCL-1/BCL-2-IN-4 is a selective and potent Mcl-1 and Bcl-2 dual inhibitor.</p>Fórmula:C26H23BrN2O5SPureza:98%Cor e Forma:SolidPeso molecular:555.44EL-102
CAS:<p>EL-102 is a HIF1α inhibitor with anticancer activity that inhibits microtubule protein polymerization and can be used to study prostate cancer.</p>Fórmula:C19H16N2O3S2Pureza:99.34%Cor e Forma:SolidPeso molecular:384.47Irbesartan HCl
CAS:<p>Irbesartan: angiotensin II blocker; treats hypertension by inhibiting receptor binding.</p>Fórmula:C25H29ClN6OPureza:98%Cor e Forma:SolidPeso molecular:465(E)-[6]-Dehydroparadol
CAS:<p>(E)-[6]-Dehydroparadol ((6)-Dehydroparadol), an oxidative metabolite of [6]-Shogaol, is a potent Nrf2 activator.</p>Fórmula:C17H24O3Pureza:99.85%Cor e Forma:SolidPeso molecular:276.37K-7174 dihydrochloride
CAS:<p>K-7174 dihydrochloride is a novel cell adhesion inhibitor; inhibits the expression of vascular cell adhesion molecule-1 (VCAM-1) induced by either IL-1β or TNF-</p>Fórmula:C33H50Cl2N2O6Pureza:99.15%Cor e Forma:SolidPeso molecular:641.67PARP14 inhibitor H10
CAS:<p>PARP14 inhibitor H10 is a selective inhibitor against PARP14 with IC50 of 490 nM</p>Fórmula:C24H27N7O7SPureza:98%Cor e Forma:SolidPeso molecular:557.58DJ001
CAS:<p>DJ001: specific PTPσ inhibitor, non-competitive, IC50=1.43 μM, aids hematopoietic stem cell regeneration.</p>Fórmula:C15H12N2O3Pureza:99.54%Cor e Forma:SolidPeso molecular:268.27CDK8/19-IN-1
CAS:<p>CDK8/19-IN-1 is a selective and oral bioavailable CDK8/19 dual inhibitor (IC50s: 0.46 nM, 0.99 nM, and 270 nM for CDK8, CDK19, and CDK9).</p>Fórmula:C19H18N4O4S2Pureza:98%Cor e Forma:SolidPeso molecular:430.5Psammaplysene A
CAS:<p>Psammaplysene A is a FOXO1a nuclear export inhibitor.</p>Fórmula:C27H35Br4N3O3Pureza:98%Cor e Forma:SolidPeso molecular:769.2W146 TFA
CAS:<p>W146 TFA is a selective sphingosine-1-phosphate receptor 1 ( S1PR1 ) antagonist with an EC 50 value of 398 nM.</p>Fórmula:C18H28F3N2O6PCor e Forma:SolidPeso molecular:456.399VII-31
CAS:<p>VII-31 is an activator of the NEDDylation pathway, capable of inducing apoptosis in MCF-7, PC-3, and MGC-803 cells.</p>Fórmula:C23H25NO5SCor e Forma:SolidPeso molecular:427.51MYRA-A
CAS:<p>MYRA-A is an inducer of apoptosis in a Myc-dependent manner that acts by inhibiting Myc-driven transformation and disrupting MYC-Max interaction.</p>Fórmula:C19H20N2O4Pureza:98%Cor e Forma:SolidPeso molecular:340.37Polyphyllin II
CAS:<p>Polyphyllin II (Chonglou Saponin II) has hemostasis, expectorant, bacteriostasis, anticytotoxic, anti-pregnancy kill sperm effects.</p>Fórmula:C44H70O16Pureza:99.92%Cor e Forma:SolidPeso molecular:855.02Epirubicin
CAS:<p>Epirubicin, a doxorubicin derivative, is an antineoplastic, inhibits topoisomerase, DNA/RNA synthesis, and Foxp3, reducing T cell activity.</p>Fórmula:C27H29NO11Cor e Forma:SolidPeso molecular:543.52SLMP53-2
CAS:<p>SLMP53-2 is a mutant p53 reactivator that restores the wild-type-like conformation and DNA-binding ability of mutp53-Y220C through enhanced interaction with</p>Fórmula:C26H22N2O2Cor e Forma:SolidPeso molecular:394.47Misetionamide
CAS:<p>Misetionamide: Oral oxathiazin-like, GAPDH inhibitor with anticancer properties for research use.</p>Fórmula:C3H7NO3SCor e Forma:SolidPeso molecular:137.16pan-HER-IN-1
CAS:<p>Compound C5: Irreversible, oral pan-HER inhibitor with low IC50s for EGFR/HERs; induces apoptosis and has antitumor effects.</p>Fórmula:C19H14BrN5OCor e Forma:SolidPeso molecular:408.25MpsBAY2a
CAS:<p>carcinoma cell proliferation.</p>Fórmula:C29H28N6OPureza:98%Cor e Forma:SolidPeso molecular:476.57TH1834 dihydrochloride
CAS:<p>TH1834 dihydrochloride is a specific Tip60 histone acetyltransferase inhibitor.</p>Fórmula:C33H42Cl2N6O3Pureza:98%Cor e Forma:SolidPeso molecular:641.63MBM-17
CAS:<p>MBM-17 is a potent inhibitor of NIMA-related kinase 2 (Nek2,IC50 of 3 nM).</p>Fórmula:C28H28N6O2Pureza:98%Cor e Forma:SolidPeso molecular:480.56NSC405640
CAS:<p>NSC405640 selectively inhibits MDM2-p53 interaction, restoring mutated p53 structure; halts growth of cells with normal p53. [1]</p>Fórmula:C12H10Cl2SnCor e Forma:SolidPeso molecular:343.82ML132
CAS:<p>ML132 is an effective and selective inhibitor of caspase 1 (IC50: 0.316 nM).</p>Fórmula:C22H28ClN5O5Cor e Forma:SolidPeso molecular:477.94KY1022
CAS:<p>KY1022 is a ras destabilizer. KY1022 targets the Wnt/ß-catenin pathway and inhibits development of metastatic colorectal cancer.</p>Fórmula:C17H19N3OSCor e Forma:SolidPeso molecular:313.42Jolkinolide B
CAS:<p>Jolkinolide B is a bioactive diterpene isolated from the roots of Euphorbia fischeriana Steud.</p>Fórmula:C20H26O4Pureza:99.39% - 99.7%Cor e Forma:SolidPeso molecular:330.42HL271
CAS:<p>HL271, a derivative of metformin, is a potent AMPK activator that increases AMPK phosphorylation. HL271 attenuates aging-associated cognitive impairment.</p>Fórmula:C13H17ClF3N5OPureza:98%Cor e Forma:SolidPeso molecular:351.76Topoisomerase IIα-IN-3
CAS:<p>Topoisomerase IIα-IN-3 is a DNA-inserting topoisomerase-Iiα inhibitor that blocks the cell cycle in G0/G1 phase and induces apoptosis.</p>Fórmula:C29H20N6O2SCor e Forma:SolidPeso molecular:516.57Glucocorticoid receptor modulator 1
CAS:<p>Glucocorticoid receptor modulator 1 is a orally NF-κB and AP-1 inhibitor, inflammatory factors IL-6, IL-1β, TNF-α, and MMP-13, alleviating skin inflammation.</p>Fórmula:C24H23ClN2O4SPureza:99.79%Cor e Forma:SolidPeso molecular:470.97EGFR-IN-56
CAS:<p>EGFR-IN-56 (13a) inhibits EGFR, EGFRT790M (IC50: 541.7nM), EGFRT790M/L858R (IC50: 132.1nM), blocks G2/M phase, and triggers apoptosis.</p>Fórmula:C23H22N4O3SCor e Forma:SolidPeso molecular:434.51Adapalene sodium salt
CAS:<p>Adapalene (CD 271; Differin) sodium salt is a synthetic retinoid and a Retinoic acid receptor agonist.</p>Fórmula:C28H28NaO3Pureza:98%Cor e Forma:SolidPeso molecular:435.519CDK1/2/4-IN-1
CAS:<p>CDK1/2/4-IN-1 inhibits CDKs (IC50: CDK1-1.47μM; CDK2-0.78μM; CDK4-0.87μM) and is useful in cancer studies, affecting apoptosis and the cell cycle.</p>Fórmula:C15H16N2O2SCor e Forma:SolidPeso molecular:288.36ACA-28
CAS:<p>ACA-28 is an ERK MAPK signalling modulator that induces apoptosis in melanoma cells by overexpressing ERK.</p>Fórmula:C17H16O6Pureza:98.73%Cor e Forma:SolidPeso molecular:316.31HS-438
CAS:<p>HS-438 inhibits imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.</p>Fórmula:C17H17N3O3SCor e Forma:SolidPeso molecular:343.4Anti-inflammatory agent 17
CAS:<p>Compound 17: Orally active, potent IL-6 & TNF-α inhibitor; not cytotoxic; promising for ALI research.</p>Fórmula:C20H23NO5Cor e Forma:SolidPeso molecular:357.4HDACs/mTOR Inhibitor 1
CAS:<p>HDACs/mTOR Inhibitor 1 is a dual HDACs and mammalian target of Rapamycin (mTOR) target inhibitor for treating hematologic malignancies (IC50s: 0.19 nM, 1.8 nM,</p>Fórmula:C28H38N8O5Cor e Forma:SolidPeso molecular:566.65SKI-I
CAS:<p>SKI-I: Human sphingosine kinase inhibitor, IC50 1.2μM; hERK2 inhibitor, IC50 11μM; promotes tumor cell apoptosis.</p>Fórmula:C25H18N4O2Cor e Forma:SolidPeso molecular:406.44SID 3712249
CAS:<p>SID 3712249 is an inhibitor of the biogenesis of microRNA-544 (miR-544).</p>Fórmula:C17H21N7Pureza:98%Cor e Forma:SolidPeso molecular:323.4PD-1/PD-L1-IN-28
CAS:<p>PD-1/PD-L1-IN-28, an inhibitor of the PD-1/PD-L1 signaling pathway (IC 50 = 0.744 µM), demonstrates promising research potential in tumor immunity.</p>Fórmula:C24H24N4O2Cor e Forma:SolidPeso molecular:400.47Epinephrine bitartrate
CAS:<p>L-Epinephrine Bitartrate is alpha- and beta-adrenergic receptor stimulator.</p>Fórmula:C13H19NO9Pureza:98.6% - 99.07%Cor e Forma:White SolidPeso molecular:333.3Caspase-3-IN-1
CAS:<p>Caspase-3-IN-1 is a potent inhibitor of Caspase-3 (IC50: 14.5 nM).</p>Fórmula:C26H25N3O6SCor e Forma:SolidPeso molecular:507.56Telomerase-IN-4
CAS:<p>Telomerase-IN-4 is a potent inhibitor of telomerase with antiproliferative properties and induces apoptosis [1].</p>Fórmula:C21H18N4OS2Pureza:98%Cor e Forma:SolidPeso molecular:406.52SS28
CAS:<p>SS28 inhibits tubulin polymerization to cause cell cycle arrest at G2/M phase.</p>Fórmula:C18H20O3Pureza:98%Cor e Forma:SolidPeso molecular:284.35Anticancer agent 147
CAS:<p>Compound 6j (Anticancer agent 147), a sophoridine derivative and ferroptosis inducer, promotes intracellular accumulation of Fe2+, reactive oxygen species (ROS</p>Fórmula:C32H40BrN3O2Pureza:98%Cor e Forma:SolidPeso molecular:578.58FW1256
CAS:<p>FW1256: phenyl analog, slow H2S donor, inhibits NF-κB, induces apoptosis, anti-inflammatory, potential cancer/cardio treatment.</p>Fórmula:C12H10NOPSCor e Forma:SolidPeso molecular:247.25Antiproliferative agent-32
CAS:<p>Antiproliferative agent-32 (Compound 1c) impedes phosphorylation within the PI3K/Akt/mTOR signaling pathway, restrains proliferation of Huh7 and SK-Hep-1 cells</p>Fórmula:C19H15NO2Pureza:98%Cor e Forma:SolidPeso molecular:289.33Atopaxar Hydrobromide
CAS:<p>Atopaxar, a reversible PAR-1 thrombin receptor antagonist, interferes with platelet signaling.</p>Fórmula:C29H39BrFN3O5Pureza:98%Cor e Forma:SolidPeso molecular:608.54Antitumor agent-115
CAS:<p>Antitumor agent-115 (SS-12) is a potent anti-tumor compound, exhibiting an IC50 range of 0.34 μM-24.14 μM against the 4T1 mouse breast cancer cell line.</p>Fórmula:C19H38ClNO2Pureza:98%Cor e Forma:SolidPeso molecular:347.962,5-Dihydroxybiphenyl
CAS:<p>2,5-Dihydroxybiphenyl: a small molecule that induces trichothiodystrophy A protein dimerization, modulating TFIIH activity.</p>Fórmula:C12H10O2Pureza:99.66%Cor e Forma:White To Grey-Brownish PowderPeso molecular:186.21Anticancer agent 59
<p>Anticancer agent 59 suppresses various cancers, notably A549 at IC50 of 0.2 μM, induces apoptosis and disrupts mitochondria in mice.</p>Fórmula:C42H59NO6Cor e Forma:SolidPeso molecular:673.92673-A
CAS:<p>673-A inhibits ALDH1A, depletes ovarian CSCs, induces necroptosis, and reverses chemo resistance.</p>Fórmula:C15H13NOCor e Forma:SolidPeso molecular:223.27
![(E)-[6]-Dehydroparadol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTM%2Fthumb-webp%2FT13436.webp&w=3840&q=75)
